Hospital General de Alicante

Alicante 03010

0 studies enrolling now · 11 studies all time

What they study most

Acute Respiratory Failure, Alzheimer Disease, Atopic Dermatitis, Breast Cancer, Coronary Artery Disease, Irritability Associated With Autism Spectrum Disorder, Lung Cancer, Necrotizing Enterocolitis, Non-Small Cell Lung Cancer, Small Cell Lung Cancer

Studies at this site

• Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder — Stopped early
• Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder — Completed
• Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05) — Completed
• Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC — Running, not enrolling
• Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3 — Completed
• IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study — Running, not enrolling
• GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease — Completed
• Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer — Completed
• BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab — Stopped early
• Third International Study on Mechanical Ventilation — Completed
• SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries — Status unconfirmed